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OBJECTIVES: Several studies have confirmed the high potential of the forced oscillation technique for the
assessment of respiratory modifications related to chronic obstructive pulmonary disease. However, most of these
studies did not employ within-breath analyses of the respiratory system. The aim of this study is to analyze
respiratory impedance alterations in different phases of the respiratory cycle of chronic obstructive pulmonary
disease patients and to evaluate their clinical use.
METHODS: 39 individuals were evaluated, including 20 controls and 19 individuals with chronic obstructive
pulmonary diseasewho experienced severe airway obstruction.We evaluated themean respiratory impedance (Zm) as
well as values for inspiration (Zi) and expiration cycles (Ze), at the beginning of inspiration (Zbi) and expiration (Zbe).
The peak-to-peak impedance (Zpp), and the impedance change (DZrs) were also analyzed. The clinical usefulness was
evaluated by investigating the sensibility, specificity and the area under the receiver operating characteristic curve.
RESULTS: The respiratory impedance increased in individuals with chronic obstructive pulmonary disease in all of the
studied parameters (Zm, Zi, Ze, Zbi, Zbe, DZrs and Zpp). These changes were inversely associated with spirometric
parameters. Higher impedanceswere observed in the expiratory phase of individualswith chronic obstructive pulmonary
disease. All of the studied parameters, except for DZrs (area under the receiver operating characteristic,0.8), exhibited
high accuracy for clinical use (area under the receiver operating characteristic .0.90; Sensibility $ 0.85; Sp $ 0.85).
CONCLUSIONS: The respiratory alterations in severe chronic obstructive pulmonary disease may be identified by the
increase in respiratory system impedance, which is more evident in the expiratory phase. These results confirm the
potential of within-breath analysis of respiratory impedance for the assessment of respiratory modifications related
to chronic obstructive pulmonary disease.
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INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a major
cause of morbidity and mortality worldwide.1 According to
World Health Organization estimates, 80 million people
have moderate to severe COPD, and more than 3 million
people died of COPD in 2005, which corresponds to 5% of
all deaths globally.2
The airway obstruction resulting from COPD is associated
with a progressive increase in airflow limitation,1 which is
usually evaluated by spirometric tests. However, these tests
require good cooperation and maximal effort by the subject.
Thus, these tests may be unreliable and variable if sub-
optimal maneuvers are performed.3
Forced oscillation technique (FOT) offers a simple,
detailed approach for investigating the mechanical proper-
ties of the respiratory system. In practice, sinusoidal
excitations are superimposed on the subject’s spontaneous
breathing at the airway opening by a loudspeaker, requiring
little patient cooperation.4-6 The resulting oscillations in air
flow and pressure are recorded and used to estimate the
mechanical impedance of the respiratory system. These
features make this technique potentially suitable for the
routine evaluation of respiratory function in COPD.7-9
Studies using the FOT often use several excitation
frequencies (multifrequency FOT) to obtain an average
result from several breathing cycles.5-9 This approach does
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not allow a detailed, individual analysis of the inspiratory
and expiratory phases of the respiratory cycle. Recently, a
version of the FOT that uses a single excitation frequency
(monofrequency FOT) was developed, and this technique
allows within-breath analysis of respiratory mechanics.10
For within-breath analysis, the system evaluates, in real
time, the module of the respiratory impedance (Zrs), which
is associated with respiratory system resistance (Rrs) and
reactance (Xrs) as described in equation 1:
Zrs~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Rrs2zXrs2
p
ð1Þ
These measurements are related to the total mechanical
load provided by the respiratory system. This method has
been successfully used to study the fast events associated
with sleep apnea10,11 and swallowing.12 Other research
groups have obtained promising results using the mono-
frequency forced oscillation technique (MnFOT) for the
detection of expiratory flow limitations in patients with
COPD,13,14 investigating physiological recovery from an
exacerbation of COPD15 and analyzing responses to deep
inhalation in asthmatic children16 and adults.17 A detailed
evaluation of the short-term variability of airway caliber in
asthma was also recently accomplished using this techni-
que.18,19 Dellaca´ et al.20 recently used MnFOT to assess
response to salbutamol in COPD patients, and Veiga et al.21
obtained promising results using this technique to investi-
gate the pathophysiology of asthmatic patients in the
diagnosis of this disease. However, there are limited data
reported on the use of respiratory impedance in the analysis
of different phases of the breathing cycle22-24 and its use in
the diagnosis of COPD. The cited studies were based on an
impulse oscillation system, which has some differences
from classical FOT, including the data processing and the
parameters used to interpret raw data.
The objectives of the present study were the following: (1)
to compare the respiratory mechanics of normal individuals
and those with COPD, with an emphasis on the differences
between phases of the respiratory cycle and (2) using
spirometry as a reference technique, to evaluate the ability
of MnFOT in the clinical diagnosis of increased airway
obstruction in patients with severe COPD.
MATERIALS AND METHODS
Study design and ethical considerations
The present work is a controlled cross-sectional study that
was developed at the State University of Rio de Janeiro. The
examinations included spirometry and FOT measurements.
These measurements were performed at the Biomedical
Instrumentation Laboratory in the Institute of Biology in
conjunction with the Pulmonary Function Laboratory at
Pedro Ernesto University Hospital. The Research Ethics
Committee of this institution approved this study. The
objectives of the study were explained to all individuals,
and their written consent was obtained before their
inclusion in the study.
Subjects
This study involved volunteers with normal spirometric
evaluations who never smoked and patients with COPD
from our outpatient clinic. Inclusion criteria for COPD
individuals were the following: older than 50 years, being of
either sex, having a diagnosis of COPD according to the
criteria of GOLD1 and the Brazilian Society of Pneumology
and Tisiology,25 and being classified as having accentuated
obstructive lung disease according to Jansen.7,26-28 The
exclusion criteria were the following: COPD exacerbation
occurring less than 90 days previously, the presence of other
chronic lung diseases, tuberculosis or pneumonia, the
presence of thoracic trauma or surgery, respiratory infec-
tions occurring less than 30 days previously and the
inability to perform examinations.
The control group consisted of healthy volunteers of both
sexes who were older than 50 years with no history of
pulmonary disease, cardiovascular disease or smoking. The
individuals selected for the control group had normal
spirometry results7,26-28 and underwent a clinical examina-
tion to observe their general health and the absence of
respiratory infections. Baseline data, including age, sex, and
height, were obtained from each patient at the time of the
test procedures.
Study protocol
The exams were previously scheduled by phone, and the
subjects were informed of the need to suspend the use of
bronchodilators during the 12 hours that preceded the tests.
On the scheduled date, the examination sequence was
carried out as follows: the evaluation of clinical history, the
collection of anthropometric measurements (age, body
weight and height) and risk factors associated with the
disease, testing FOT impedance, and, finally, gathering
spirometric measurements.
Within-breath respiratory impedance
measurements
The system used for respiratory impedance analysis was
developed in our laboratory. It is based on equipment
described previously by our group for the study of
respiratory disorders during sleep.10,11 Briefly, the instru-
ment applies a single frequency (5 Hz), low pressure
(2.0 cmH2O) sinusoidal signal to the subject’s respiratory
system, which remains under spontaneous ventilation.
Pressure (P) and flow (V’) transducers placed near the
subject’s mouth are used in the measurement of these
variables. The resulting signals are recorded by an analog
signal processing circuit to perform calculations to obtain
the Zrs (Zrs = P/V’) in real time. This variable is known as
the impedance module and describes the total mechanical
load of the respiratory system, including the effects of
resistance and reactance.11,21 The instrument was calibrated
by means of a reference mechanical load and, after this,
measurement errors were ,0.5%.10,11 The system program
was developed in the LabView 8.2 environment and permits
the control of the beginning and end of the exam as well as
the visualization of respiratory impedance alterations that
occur during the phases of the breathing cycle.10,11 This
allows an easy evaluation of the reproducibility of a
patient’s impedance values during the tests. We discarded
distortions during the recording that were due to artifacts
such as coughs or sneezes. Whenever the impedance time
series was not considered adequate, the maneuver was not
considered valid and was repeated. When correct maneu-
vers could not be obtained, the volunteers were excluded
from the study.
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The mechanical alterations during different phases of the
respiratory cycle were characterized using the following
secondary parameters:
N The mean respiratory impedance (Zm), calculated for
the complete exam;
N The mean impedance during the inspiration cycles (Zi);
N The mean impedance during the expiration cycles (Ze);
N The mean impedance at the beginning of inspiration
(Zbi);
N The mean impedance at the beginning of expiration
(Zbe);
N The peak-to-peak impedance (Zpp), the difference
between Zbe and Zbi;
N The mean change in the impedance (DZrs), the differ-
ence between Ze and Zi.
Spirometry
Spirometry tests were performed using a flow spirometer
(Micro Medical, model MicroLoop, SP, Brazil). The tests
followed procedures recommended by the Brazilian
Consensus on Spirometry29 and were performed by a
trained technician, as described by the Brazilian Thoracic
Society.25 The following parameters were considered:
N Forced expiratory volume in one second (FEV1);
N Forced vital capacity (FVC);
N FEV1/FVC ratio;
N Forced expiratory flow between 25-75% of FVC (FEF25-75);
N The FEF/FVC.
All parameters were assessed as absolute and percentage
values relative to the value predicted for gender, age and
height according to Pereira et al.30 and following the criteria
established by the American Thoracic Society and European
Respiratory Society.31,32 FOT exams were carried out first,
and the delay between FOT and spirometric exams was less
than thirty minutes.
Sample size and statistical analysis
To estimate the sample size, a pilot study in a group of 20
subjects (10 subjects with COPD and 10 controls) was
conducted using a protocol identical to that described
above. Based on these preliminary results, the software
MedCalcH 8.2 (Medicalc Software Mariakerke, Belgium) was
used to calculate the sample size based on the difference
between means, assuming type I and type II errors of 1%.
The minimum calculated value for this study consisted of 12
individuals for each group.
Data are presented as means¡SD. Initially, the character-
istics of the samples were evaluated using the Shapiro-Wilk
test. Next, depending on the characteristic, we used the
independent Student’s t test or Mann-Whitney U test to
assess differences between-groups and the paired t test and
one-way ANOVA analysis for intra-group differences.
These analyses were performed using STATISTICAH 5.0
for Windows (StatSoft Inc., Tulsa, USA). Differences were
considered statistically significant when p,0.05.
The associations between variables related to spirometry
and within-breath respiratory impedance tests were inves-
tigated using Pearson’s correlation coefficient for the entire
group of studied subjects. These tests were carried out using
OriginH 6.0 (Microcal Software, MA, USA).
The clinical potential of using FOT indices for the
detection of respiratory alterations in patients with COPD
was evaluated with receiver operating characteristic (ROC)
analyses, which were conducted using MedCalcH 8.2
(Medicalc Software Mariakerke, Belgium).
RESULTS
A total of 48 subjects completed the evaluation protocol;
of these subjects, 39 had technically satisfactory measure-
ments. Four patients with COPD (17% of the original COPD
group) and five controls (20% of the total control group)
produced unsatisfactory measurements due to irregular
breathing changes during FOT measurements. The anthro-
pometric and spirometric characteristics of the studied
subjects are summarized in Table 1. Body weight and BMI
values were significantly smaller in the COPD group as
compared to the control group (p,0.001) while age and
height were similar between these groups. As shown in
Table 1, patients with COPD exhibited significant reduc-
tions in all of the studied spirometric parameters (p,0.03).
Table 2 shows the results obtained from evaluation of
respiratory system impedance during the respiratory cycle
of patients with COPD as compared to controls. The
respiratory impedances were always significantly higher
in COPD patients than in the control group (Zm, Zbi, Zi,
Zbe and Ze; p,0.001). Similar comparisons revealed that
Zpp (p,0.001) and DZrs (p,0.005) were significantly
increased in patients with COPD.
Comparisons of the different respiratory cycle phases in
COPD and healthy subjects are shown in Figure 1. The
respiratory impedance did not change significantly during
the respiratory cycle in the control group (ANOVA, p= ns).
Conversely, the Zrs were significantly increased in the
COPD group when the cycle from the beginning of the
inspiratory phase to the end of the expiratory phase was
considered (ANOVA, p,0.005). Figure 1 also shows that Ze
was significantly higher than Zi (p,0.001) and Zbe was
significantly higher than Zbi (p,0.001) in patients with
COPD.
Table 1 - Biometric and spirometric characteristics of the
studied subjects.
COPD
(n=19)
Control
(n = 20) p-value
M/F 14/05 07/13 -
Age (years) 71.3¡8.1 68.3¡8.3 ns
Weight (kg) 56.8¡10.4 73.5¡12.3 0.001
Height (m) 1.60¡0.10 1.63¡0.08 ns
BMI (kg/m2) 21.90¡3.50 27.79¡4.4 0.001
FVC (L) 2.38¡0.8 2.89¡0.61 0.03
FVC (%) 76.6¡21.8 94.4¡15.42 0.005
FEV1 (L) 0.84¡0.28 2.33¡0.59 0.0001
FEV1 (%) 36.5¡11.0 97.4¡14.64 0.0001
FEV1/FVC 37.3¡9.0 80.25¡6.23 0.0001
FEF/FVC 12.7¡6.7 78.09¡22.23 0.0001
FEF25-75 (L) 0.28¡0.1 2.31¡0.94 0.0001
FEF25-75 (%) 12.2¡5.2 97.25¡28.1 0.0001
COPD: Chronic Obstructive Pulmonary Disease; n: number of subjects; ns:
non-significant;
BMI: body mass index; FEV1: forced expiratory volume in one second; FVC:
forced vital capacity; FEF: forced expiratory flow; %: percentage of the
predicted value.
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The associations between FOT and spirometric para-
meters are described in Table 3. Zm, Zi, Ze, Zbi and Zbe
values presented statistically significant inverse correlations
with all spirometric parameters. Similar behavior was
observed for Zpp and DZrs, but Zpp was not associated
with FVC (L) and DZrs was not associated with FVC (%).
When the correlation coefficients are compared, Zm, Zi, Ze,
Zbe and Zpp were observed to have a higher association
with FEV1 (%),Zbi was more associated with FEF25-75% and
DZrs was more closely associated with FEV1 (L).
Table 4 summarizes the results for the evaluation of the
clinical potential of the studied indices. Six of the seven
studied parameters presented AUC $ 0.9.
DISCUSSION
In this study, we observed that severe COPD may be
identified by the increase in within-breath respiratory
system impedance. Our data suggested that this is more
evident in the expiratory phase, and confirms the clinical
potential of within-breath impedance analysis for the
diagnosis of respiratory modifications related to COPD.
Twenty percent of the initial control group and 17% of the
initial group of patients with COPD were excluded from the
study due to inadequate FOT measurements. This percentile
values may be associated with a characteristic of this sample
of volunteers, because these volunteers do not presented
experience with FOT. Individuals comprising the group of
patients with COPD had body mass and BMI values that
were smaller than those in the control group (Table 1). This
difference is likely due to the clinical condition of these
patients, who suffer from advanced COPD. The alterations
in routine lung function parameters in COPD patients were
consistent with the presence of severe airway obstruc-
tion,1,32 leading to decreased spirometric results (Table 1).
An FEV1/FVC ratio below 70% indicates the presence of
airflow obstruction,1,32 while an FEV1(%) below 50%
indicates the presence of severe obstructive ventilatory
insufficiency,1,33 The FVC was reduced in these patients,
indicating the presence of a predominantly obstructive
process with probable pulmonary hyperinsuflation.34
In this study, we evaluated the respiratory system
impedance module, which is associated with the resistive
and reactive properties of the entire respiratory system,
including the lung and chest wall.4-6 COPD is characterized
by the presence of airway wall inflammation, and the
consequent reduction in bronchial and bronchiolar quality,
as well as mucus hypersecretion, results in airway obstruc-
tion.1,7 These factors, alone or associated, are responsible for
increased airway resistance. In addition to the increased
resistance observed in COPD, a decrease in dynamic
compliance is also present. This decrease may be explained
using the concept of a ‘‘choke point’’, introduced by Dellaca`
et al.,13 and describes the difficulty that the oscillatory
signals emitted by the FOT encounter when crossing
segments of the bronchial tree; this difficulty is associated
with increased small airway resistance.35 This event induces
a fall in the dynamic compliance and a consequent increase
in the impedance module. Consistent with this theory, all of
the analyzed parameters were significantly increased in
COPD subjects (Table 2). The observed changes in Zm
describe the increase in respiratory work associated with the
previously mentioned changes.
Table 2 - Comparative analysis between COPD and
control subjects considering the impedance in different
phases of the ventilatory cycle.
COPD Control p-value
Zm (cmH2O\L\s) 10.0¡2.8 4.6¡1.2 0.001
Zi (cmH2O\L\s) 9.0¡2.5 4.4¡1.2 0.001
Ze (cmH2O\L\s) 10.5¡3.1 4.7¡1.3 0.001
Zbi (cmH2O\L\s) 8.1¡2.0 4.3¡1.3 0.001
Zbe (cmH2O\L\s) 11.0¡3.1 4.8¡1.3 0.001
Zpp (cmH2O\L\s) 2.93¡2.02 0.50¡0.74 0.001
DZrs (cmH2O\L\s) 1.49¡1.65 0.27¡0.57 0.005
Zm – Mean impedance of the respiratory system; Zi – inspiratory
impedance; Ze – expiratory impedance; Zbi – impedance at the beginning
of inspiration; Zbe – impedance at the beginning of expiration. Zpp –
peak-to-peak variation of the impedance; DZrs – variation of the mean
impedance.
Figure 1 - Mean Zrs values during the ventilatory cycle in COPD
(red lines) and healthy subjects (blue lines).
Table 3 - Area under the curve (AUC), sensitivity (Se),
specificity (Sp) and cut-off point of the Forced Oscillation
parameters.
AUC Se (%) Sp (%) Cut-off
Zm (cmH2O/L/s) 0.974
(0.86-1.00)
94.7
(73.9-99.1)
95.0
(75.1-99.2)
6.2
Zi (cmH2O/L/s) 0.963
(0.85-0.99)
94.7
(73.9-99.1)
90.0
(68.3-98.5)
5.6
Ze (cmH2O/L/s) 0.976
(0.87-1.00)
100.0
(82.2-100.0)
90.0
(68.3-98.5)
5.7
Zbi (cmH2O/L/s) 0.958
(0.84-0.99)
94.7
(73.9-99.1)
90.0
(68.3-98.5)
5.4
Zbe (cmH2O/L/s) 0.971
(0.86-1.00)
94.7
(73.9-99.1)
95
(75.1-99.2)
6.2
Zpp (cmH2O/L/s) 0.903
(0.76-0.97)
89,5
(66.8-98.4)
85
(62.1-96.6)
1.3
DZrs (cmH2O/L/s) 0.766
(0.60-0.89)
78.9
(45.7-88.0)
78.9
(54.4-93.8)
0.37
Values are presented as mean and confidence interval (95%); Zm – mean
impedance of the respiratory system; Zi – inspiratory impedance; Ze –
expiratory impedance; Zbi – impedance at the beginning of inspiration;
Zbe – impedance at the beginning of expiration. Zpp – peak-to-peak
variation of the impedance; DZrs – variation of the mean impedance.
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In a previous study, Clement et al.36 investigated the
behavior of Rrs and Xrs in individuals with and without
airway obstruction. These authors associated higher values
of Rrs and Xrs with increased degrees of airway obstruction,
findings that were associated with the pathophysiological
progression of COPD. Van Noord et al.34 evaluated the
respiratory system resistance of 125 individuals with severe
airway obstruction using the FOT at 6 Hz. The authors
observed increased resistance values in patients with COPD
as compared to healthy subjects. The increase in Rrs due to
COPD was also demonstrated by Zerah et al.,9 who studied
the effect of a bronchodilator using multifrequency FOT.
According to these authors, this resistance pattern, which is
consistent with the lower FEV1 values identified in this
population, is associated with the presence of airway
obstruction and consequent non-homogeneous lung capa-
city. The study conducted by Farre´ et al.38 evaluated
respiratory impedance in mechanically ventilated COPD
patients. Rrs and Xrs curves showed that resistance values
increased and that reactance values were more negative,
which are consistent with our results (Table 2, Figure 1). By
analyzing the mechanical changes in the respiratory system
resulting from increased levels of airway obstruction in
COPD, Di Mango et al.7 also found that resistance values
were increased and that reactance values were more
negative. Other characteristics may contribute to the
presence of higher Zm values, such as reductions in the
homogeneity of the lung time constants.7,13,27,39 Based on
equation (1), the increase in Zm observed in our study
(Table 2) as well as the significant inverse correlations
between Zm and spirometric parameters (Table 3) are
consistent with these previously published results23,24,39 and
physiological aspects of COPD.1,35
In the present study, subjects with COPD exhibited higher
impedance in all phases of the ventilatory cycle when
compared to control subjects (Table 2; Figure 1). The
advanced stage of COPD observed in our patients is
associated with peribronchial fibrosis and consequent
airway tissue remodeling. Thus, this reduced airway
compliance may introduce more negative Xrs, contributing
to higher Zrs (equation (1)). Higher values of inspiratory
and expiratory impedances were also observed by
Cavalcanti et al.21 in their comparison between asthmatic
and healthy subjects using methodology similar to that used
in this paper. One possible contributing factor for these
results is the recruitment of accessory muscles in COPD
subjects due to impaired diaphragmatic mechanics. In
COPD, the change in the tidal volume operating point
favors lung hyperinflation, reducing the efficiency of the
diaphragm as a pump and inducing the use of accessory
muscles. Because respiratory impedance measurements
include the influence of the chest wall, we believe that
abnormal accessory muscle contraction during inspiration
may contribute to the increased Zi in our patients.
The Zrs values observed throughout the respiratory cycle
were similar in both groups (Figure 1); Zrs values increased
from the beginning of inspiration to expiration. Paredi et
al.22 observed only minimal changes in Rrs and Xrs values
between inspiration and expiration in normal individuals.
Consistent with these results, we observed only non-
significant changes in Zrs in healthy subjects (Figure 1).
However, patients with COPD showed significant changes
in Zrs among the phases of the respiratory cycle (Figure 1;
p,0.005). Consistent with the results obtained by Dellaca` et
al.13 and Johnson et al.,15 Zrs values were higher during
expiration than inspiration in patients with COPD.
Analysis of Zrs during expiration has been used to
establish the presence of expiratory flow limitation
(EFL).13,15 During EFL events, increased Zrs values are
observed. In this context, Zbe and Ze are expected to be
higher than Zbi and Zi in patients with COPD. The results
described in Figure 1 indicate that EFL may be a significant
component affecting respiratory impedance in the studied
subjects.
Using an impulse oscillation system, Paredi et al.22
investigated whether oscillometric indices differ between
patients with asthma and patients with COPD. Consistent
with the results of the present work, these authors observed
that expiratory reactances at 5 Hz were significantly less
than inspiratory reactances in patients with COPD. These
results are also consistent with those recently described by
Kubota et al.23 and Kanda et al.24
The control subjects exhibited minimal variations in DZrs
and Zpp (Table 2, Figure 1), which are consistent with
previous studies.13-15,24 Conversely, Table 2 shows that
COPD subjects experienced significant increases in DZrs
and Zpp. Previous authors have also observed more
substantial expiratory-inspiratory differences in patients
with COPD than in healthy subjects.22-24
Table 4 - Pearson correlation coefficient (r), and p-value (p) between FOT and spirometry.
Zm
(cmH2O/L/s)
Zi
(cmH2O/L/s)
Ze
(cmH2O/L/s)
Zbi
(cmH2O/L/s)
Zbe
(cmH2O/L/s)
Zpp
(cmH2O/L/s)
DZrs
(cmH2O/L/s)
FVC (L) r -0.57 -0.53 -0.57 -0.56 -0.48 -0.25 -0.40
p 0.001 0.001 0.001 0.001 0.002 0.1 0.02
FVC (%) r -0.59 -0.59 -0.56 -0.55 -0.54 -0.38 -0.20
p 0.001 0.001 0.001 0.001 0.001 0.02 0.2
FEV1 (L) r -0.77 -0.74 -0.77 -0.75 -0.76 -0.56 -0.50
p 0.001 0.001 0.001 0.001 0.001 0.001 0.002
FEV1 (%) r -0.79 -0.78 -0.78 0.75 -0.80 -0.63 -0.40
p 0.001 0.001 0.001 0.001 0.001 0.001 0.02
FEV1/FVC r -0.71 -0.69 -0.71 -0.69 -0.74 -0.60 -0.40
p 0.001 0.001 0.001 0.001 0.001 0.001 0.02
FEF/FVC r -0.74 -0.72 -0.75 -0.74 -0.76 -0.57 -0.46
p 0.001 0.001 0.001 0.001 0.001 0.001 0.004
FEF25-75 (L) r -0.73 -0.70 -0.74 -0.72 -0.74 -0.54 -0.46
p 0.001 0.001 0.001 0.001 0.001 0.001 0.004
FEF25-75 (%) r -0.78 -0.76 -0.77 -0.76 -0.78 -0.60 -0.40
p 0.001 0.001 0.001 0.001 0.001 0.001 0.01
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In our understanding as well as that of other authors,40,41
the behavior of Zrs throughout the respiratory cycle in
patients with COPD is a controversial topic with several
unclear components of the pathophysiology. Further studies
are needed to improve our understanding, e.g., concerning
the effects of a process dominated by emphysema (elastic
changes) or chronic bronchitis (obstructive changes).
Zm, Zi, Ze, Zbi and Zbe were significantly and inversely
associated with FEV1 and FVC (Table 3), which link these
impedance parameters with airway obstruction and pul-
monary volume reductions. Notably, the highest coefficient
of determination was observed between FEV1 (%) and Zbe,
whereas weaker associations were observed when Zpp and
DZrs were considered.
Johnson and colleagues39 compared Rrs and Xrs at 5 Hz
with pulmonary resistance (RL), as assessed by the use of an
esophageal balloon. Their results indicated that these
parameters can be used as predictors of RL. In this case,
the greatest advantage of FOT from the perspective of
clinical application lies in the fact that the evaluation of Rrs
and Xrs by FOT does not involve the use of an invasive
procedure, which is necessary for the evaluation of RL with
an esophageal balloon. These authors highlighted the strong
potential of this approach for scientific and clinical applica-
tion of real-time assessment of Rrs and Xrs and suggested
that the clinical use of these parameters should be system-
atically evaluated.39
To contribute in this direction, ROC curves were elabo-
rated. According to the literature, ROC curves with AUCs
between 0.50 and 0.70 indicate low diagnostic accuracy,
AUCs between 0.70 and 0.90 indicate moderate diagnostic
accuracy, and AUCs between 0.90 and 1.00 indicate high
diagnostic accuracy.42,43 An AUC.0.80 is usually considered
to be adequate for clinical use.42,43 Thus, AUC values for Zm,
Zi, Ze, Zbi, Zbe and Zpp represented highly accurate
measurements (Table 4). However, DZrs values do not attain
adequate values for clinical use. Under these conditions, Ze
was the most suitable for correctly identifying the effects of
COPD, with a sensitivity of 100% and a specificity of 90%.
These promising results are consistent with those obtained
previously21,44 and suggest that the Zrs observed in different
phases of the respiratory cycle may be useful in the detection
of COPD.
When the results of the present study are compared with
those obtained in a previous study our group conducted in
asthmatic subjects,21 both studies were found to provide
similar results with AUCs above 0.9, indicating high
diagnostic accuracy. The AUC values determined in these
studies are superior to those obtained in previous studies
using multifrequency FOT that were performed in patients
with COPD45 (maximum AUCs of 0.85), in asthmatic
patients27 (maximum AUCs of 0.88), and in patients with
sarcoidosis28 (maximum AUCs of 0.84). Thus, our results
confirm the hypothesis that monofrequency FOT can attain
higher diagnostic accuracy than its corresponding multi-
frequency counterpart.21
There are three potential limitations in the present study.
First, it is important to note that the description of
sensitivity, specificity and accuracy is dependent on the
population studied, and that the present work was
conducted in patients with severe airway obstruction.
Studies in patients with mild and moderate airflow
obstruction are still necessary to confirm this hypothesis.
The second possible limitation is that the reproducibility
of the FOT measures was not evaluated in our patients with
COPD. Dellaca` et al.46 recently evaluated the reproducibility
of within breath respiratory resistance during home
monitoring. These authors showed a discrepancy of
resistance of 0.10¡0.01 cmH2O/L/s in COPD patients,
and pointed out that FOT yields accurate and reproducible
data in COPD patients. Therefore, the lack of reproducibility
evaluation probably is not a problem in the present study.
The third possible limitation is that, in order to evaluate
the contribution of the MnFOT in the diagnosis of COPD,
we performed a study using spirometry as a reference. One
could argue that a comparison between these methods
would also be useful. In fact, our research group recently
performed this comparison in groups of smokers with very
interesting results. FOT parameters were more accurate
than spirometric indices to identify small alterations due to
smoking,44,47 while in patients with higher tobacco con-
sumption, the diagnostic performance of the FOT was
similar to that observed in spirometry.44 These studies were
conducted using multifrequency FOT. However, in the
present paper, the spirometry is used as a reference
technique, and therefore we cannot make a direct compar-
ison between spirometry and FOT. In the previously cited
papers,44,47 we compared these two techniques using the
amount of tobacco consumption (pack-years) as a reference.
Thus, although it is a really intriguing question, we cannot
evaluate it in the present paper.
Individuals with COPD and severe airway obstruction
present respiratory impedances higher than those observed
in healthy individuals in all phases of the respiratory cycle.
Thus, the impedance changes observed in individuals with
COPD reflect the high mechanical load imposed on the
respiratory system of these patients, and these changes are
consistent with the pathophysiology of the disease. These
patients experience higher impedances in the expiratory
phase than in the inspiratory phase, indicating that
expiratory flow limitation may play a significant role in
severe COPD. Several of the studied parameters demon-
strated high accuracy for the diagnosis of COPD. These
results indicate that the evaluation of respiratory impedance
in different phases of the respiratory cycle may be a
promising clinical diagnostic tool, representing an alter-
native and/or complementary technique to other conven-
tional exams used to clinically evaluate patients with COPD.
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